Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 4
Out of 5,182 analysts
133
Total ratings
63.64%
Success rate
152.23%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 → $1,450 | $1,322.76 | +9.62% | 9 | Mar 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $198.81 | +10.66% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $90.40 | +16.15% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $196.19 | +40.17% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $8.00 | +12.50% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $91.98 | +27.20% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $318.53 | +20.87% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $116.92 | +32.57% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $65.59 | +21.97% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $15.32 | +187.21% | 6 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $274.72 | +5.56% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $8.22 | +167.64% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $41.27 | +28.35% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $51.17 | -31.60% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $23.02 | +4.26% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.47 | +172.11% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $3.13 | -4.15% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $210.83 | -32.65% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $92.84 | -65.53% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $128.00 | -10.16% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.77 | +319.29% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $503.46 | +29.11% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.24 | -40.94% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.29 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.69 | +610.06% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $3.50 | +1,614.29% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.86 | +373.25% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $175.07 | +122.77% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.09 | +482.52% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $462.28 | -56.74% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $26.66 | -9.98% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.99 | +275.31% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $119.77 | -41.55% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $172.54 | -30.45% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.36 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $38.25 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $7.37 | +646.27% | 1 | Jul 19, 2016 |
Mettler-Toledo International
Mar 20, 2026
Upgrades: Buy
Price Target: $1,400 → $1,450
Current: $1,322.76
Upside: +9.62%
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $198.81
Upside: +10.66%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $90.40
Upside: +16.15%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $196.19
Upside: +40.17%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $8.00
Upside: +12.50%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $91.98
Upside: +27.20%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $318.53
Upside: +20.87%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $116.92
Upside: +32.57%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $65.59
Upside: +21.97%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $15.32
Upside: +187.21%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $274.72
Upside: +5.56%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.22
Upside: +167.64%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $41.27
Upside: +28.35%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $51.17
Upside: -31.60%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $23.02
Upside: +4.26%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.47
Upside: +172.11%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $3.13
Upside: -4.15%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $210.83
Upside: -32.65%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $92.84
Upside: -65.53%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $128.00
Upside: -10.16%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.77
Upside: +319.29%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $503.46
Upside: +29.11%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.24
Upside: -40.94%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.29
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.69
Upside: +610.06%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $3.50
Upside: +1,614.29%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.86
Upside: +373.25%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $175.07
Upside: +122.77%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.09
Upside: +482.52%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $462.28
Upside: -56.74%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $26.66
Upside: -9.98%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.99
Upside: +275.31%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $119.77
Upside: -41.55%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $172.54
Upside: -30.45%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.36
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $38.25
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $7.37
Upside: +646.27%